NEW ORLEANS, LA—A polypill containing three out of the four pillars of guideline-directed medical therapy (GDMT) improves numerous outcomes in patients who have heart failure with reduced ejection ...

NEW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection fraction improved cardiac function and reduced the risks for serious medical ...

Welcome to Med Op-Ed, where we highlight recently published editorials. In this installment: Why exercise should be prescribed for hypertension; how to keep artificial intelligence (AI) from eroding ...

Please provide your email address to receive an email when new articles are posted on . A polypill strategy improved clinical outcomes and quality of life for people with heart failure with reduced ...

The polypill improved left ventricular ejection fraction, reduced hospitalizations, and enhanced quality of life in HFrEF patients over six months. The trial addressed polypharmacy challenges, showing ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...

The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of hypertension in adults, including as initial treatment. This marks the first ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the first polypill designed for initial treatment of hypertension. Approval was based on the ...

A team of researchers from Tehran University of Medical Sciences has found a simple and affordable way to lower the risk of serious heart problems such as heart attacks, strokes, and heart failure.

A cardiovascular polypill could be a cost-effective tool for reducing health disparities and improving patient quality of life, according to a Jan. 8 study published in JAMA Cardiology. Researchers ...

* On March 5th, 2025, headlines in the mainstream media reported “NHS ‘should give all over-50s statins’” and “NHS should offer ‘polypill’ to cut heart disease, experts urge.” * The headlines came ...